Director, Health Care Senior Analyst
Areas of focus: Health Care
Matt leads RSM’s health care valuation consulting group. In this capacity, Matt helps health care clients evaluate mergers, acquisitions, joint ventures, and other growth strategies.
In January 2018, Matt was selected as a senior analyst RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions impacting middle market leaders. Matt’s focus is on the health care industry.
Wearable tech’s transformative power promotes healthy lifestyles, lowers insurance coverage spending and increases employee engagement.
Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.
Life sciences companies must address the growing trove of data as they seek to bring personalized therapies, drugs and devices to market.
Medicaid expansion in 2019 could positively affect health care providers in states with the expanded government benefit.
Get a recap of our health care industry webcast on consumerism and its impact on health and hospital organizations.
Learn the valuation impacts resulting from the TCJA and its effect on business owners and investors assessment of ownership interests.